Synthesis and preliminary evaluation of trans-3,4-conformationally-restricted glutamate and pyroglutamate analogues as novel EAAT2 inhibitors

被引:9
|
作者
Denton, TT
Seib, T
Bridges, RJ
Thompson, CM [1 ]
机构
[1] Univ Montana, Dept Chem, Missoula, MT 59812 USA
[2] Univ Montana, COBRE Ctr Struct & Funct Neurosci, Dept Pharmaceut Sci, Missoula, MT 59812 USA
关键词
D O I
10.1016/S0960-894X(02)00520-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Select trans-4,5-[bi]cyclohexenylglutamic and pyroglutamic acids (3,4-substituted glutamates) were synthesized in three steps and were screened as potential inhibitors of the sodium dependent excitatory amino acid transporters 2 (EAAT2) and 3 (EAAT3), the chloride dependent glial cystine/glutamate exchanger system x(c)(-), and the glutamate vesicular transport system (VGLUT). Two glutamate analogues and one pyroglutamate analogue were found to inhibit EAAT2 with activity comparable to dihydrokainate. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3209 / 3213
页数:5
相关论文
共 50 条
  • [31] Synthesis, evaluation, and computational simulations of novel 1,2,3-triazole analogues of sitagliptin as DPP-4 inhibitors
    Hong, Kwon
    Vo, Duy Viet
    Park, Haeil
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [32] Design, Synthesis, and Computational Evaluation of 3,4-Dihydroquinolin-2(1H)-One Analogues as Potential VEGFR2 Inhibitors in Glioblastoma Multiforme
    Buhlak, Shafeek
    Abad, Nadeem
    Akachar, Jihane
    Saffour, Sana
    Kesgun, Yunus
    Dik, Sevval
    Yasin, Betul
    Bati-Ayaz, Gizem
    Hanashalshahaby, Essam
    Turkez, Hasan
    Mardinoglu, Adil
    PHARMACEUTICALS, 2025, 18 (02)
  • [33] Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues
    Li, Yan-Hong
    Zhang, Bei
    Yang, Hai-Kui
    Li, Qiu
    Diao, Peng-Cheng
    You, Wen-Wei
    Zhao, Pei-Liang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 1098 - 1106
  • [34] Synthesis and preliminary biological evaluation of (2S,1′R,2′S)-and (2S,1S,2′R)-2-(2′-phosphonocyclopropyl)glycines, two novel conformationally constrained L-AP4 analogues
    Amori, L
    Serpi, M
    Marinozzi, M
    Costantino, G
    Diaz, MG
    Hermit, MB
    Thomsen, C
    Pellicciari, R
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (01) : 196 - 199
  • [35] Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid:: A novel conformationally restricted glutamic acid analogue
    Bunch, L
    Liljefors, T
    Greenwood, JR
    Frydenvang, K
    Bräuner-Osborne, H
    Krogsgaard-Larsen, P
    Madsen, U
    JOURNAL OF ORGANIC CHEMISTRY, 2003, 68 (04): : 1489 - 1495
  • [36] Design, Synthesis and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors
    Sun, Ying
    Bai, Yujun
    He, Xirui
    Bai, Yajun
    Liu, Pei
    Zhao, Zefeng
    Chen, Xufei
    Zheng, Xiaohui
    MOLECULES, 2017, 22 (11):
  • [37] Design, synthesis and evaluation of novel 2-hydroxypyrrolobenzodiazepine-5,11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitors
    Addla, Dinesh
    Jallapally, Anvesh
    Kanwal, Abhinav
    Sridhar, Balasubramanian
    Banerjee, Sanjay K.
    Kantevari, Srinivas
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (15) : 4485 - 4493
  • [38] Design, Synthesis, and Insecticidal Activity of 3-(6-Methyltriazinone)-3,4-dihydrobenzo[b][1,5]diazin-2(1H)-ones: Conformationally Restricted Pymetrozine Analogues
    Li, Xiaoyang
    Zhou, Cong
    Yang, Wulin
    Li, Zhong
    Cheng, Jiagao
    CHEMISTRYSELECT, 2024, 9 (42):
  • [39] Synthesis and preliminary cytotoxic evaluation of novel 3,4-dihydro-2H-1,2,4-benzotiadiazine-1,1-dioxide derivatives
    Restrepo, Jelem
    Pérez, Yelsi
    Salazar, Jose
    Charris, Jaime
    Arvelo, Francisco
    Lopez, Simon E.
    HETEROCYCLIC COMMUNICATIONS, 2006, 12 (05) : 341 - 346
  • [40] Synthesis, preliminary evaluation and molecular modeling studies of new, conformationally constrained analogues of the competitive NMDA receptor antagonist 4-(phosphonomethyl)-2-piperidinecarboxylic acid (CGS 19755)
    Pellicciari, R
    Marinozzi, M
    Natalini, B
    Costantino, G
    Lankin, DC
    Snyder, JP
    Monahan, JB
    FARMACO, 1997, 52 (6-7): : 477 - 486